Understanding the relationship between the frequency of HbA1c monitoring, HbA1c changes over time, and the achievement of targets: a retrospective cohort study
Mukonda E, van der Westhuizen DJ, Dave JA, et al.
BMC Endocr Disord. 2025;25(1):3.
Leggi
Breaking news
Real-world retrospective study in elderly patients aged 65 years and older with type 2 diabetes mellitus treated with daily oral semaglutide (SEMA-elderly)
Fiore V, Carbotta G, Barraco S, et al.
Diabetes Obes Metab. Pub. online 10 Jan 2025.
Leggi
Trends and analysis of risk factor differences in the global burden of chronic kidney disease due to type 2 diabetes from 1990 to 2021: A population-based study
Wang Y, Lin T, Lu J, et al.
Diabetes Obes Metab. Pub. online 13 Jan 2025.
Leggi
Socioeconomic and mental health inequalities in global burden of type 2 diabetes: Evidence from the Global Burden of Disease Study 2021
Chen M, Dou C, Ye C, et al.
Diabetes Obes Metab. Pub. online 6 Jan 2025.
Leggi
Subtypes of gestational diabetes mellitus are differentially associated with newborn and childhood metabolic outcomes
Osmulski ME, Yu Y, Kuang A, et al.
Diabetes Care. 2025:dc241735.
Leggi
Psychological interventions for depression in people with diabetes mellitus
Tully PJ, Schutte N, Guppy MP, et al.
Cochrane Database Syst Rev. 2025;1(1):CD016005.
Leggi
Eating disorders among people with and without type 1 diabetes: incidence and treatment in a nationwide population-based cohort
Hirvelä L, Haukka J, Keski-Rahkonen A, Sipilä PN
Diabetologia. Pub. online 4 Jan 2025.
Leggi
Diabetes, subclinical myocardial injury or stress and risk of heart failure subtypes: the Jackson Heart study
Kaze AD, Bertoni AG, Fox ER, et al.
Diabetes Care. 2025:dc240654.
Leggi
Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to -4 trials
Rubino DM, Pedersen SD, Connery L, et al.
Diabetes Obes Metab. Pub. online 9 Jan 2025.
Leggi
Tirzepatide associated with reduced albuminuria in participants with type 2 diabetes: pooled post hoc analysis from the randomized active- and placebo-controlled SURPASS-1-5 clinical trials
Apperloo EM, Tuttle KR, Pavo I, et al.
Diabetes Care. 2025:dc241773.
Leggi